P.1.007 Th1, Th2 and Th3 cytokine alterations in bipolar disorder: Effects of mood stabilizers

Y.K. Kim; Aye-Mu Myint; Hans‐Jürgen Möller; H.W.M. Steinbusch; Michael Maes; B. E. Leonard

doi:10.1016/s0924-977x(04)80096-8

Related publications

Chapter in a book2019

Chapter 8. Mood Stabilizers and Antipsychotic Medications in Bipolar II Disorder

Eva Solé, Marina Garriga, Eduard Vieta

Article2016

Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder

Isabella Pacchiarotti, Jordi León‐Caballero, Andréa Murru, Norma Verdolini, Maria Antonietta Furio, Corinna Pancheri, Marc Valentí, Ludovic Samalin, Eva Solé Roigé, Ana González‐Pinto, José Manuel García Montes, Antonio Benabarre, José Manuel Crespo, Consuelo de Dios Perrino, José Manuel Goikolea, Luís Gutiérrez-Rojas, André F. Carvalho, Eduard Vieta

Article2015

Management of Adverse Effects of Mood Stabilizers

Andréa Murru, Dina Popović, Isabella Pacchiarotti, Diego Hidalgo, Jordi León‐Caballero, Eduard Vieta

Article2017

Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles

Poliana Macedo Guimarães, Bruna Miglioranza Scavuzzi, Nicole Perugini Stadtlober, Lorena Flor da Rosa Franchi Santos, Marcell Alysson Batisti Lozovoy, Tatiana Mayumi Veiga Iriyoda, Neide Tomimura Costa, Edna Maria Vissoci Reiche, Michael Maes, Isaías Dichi, Andréa Name Colado Simão

Article1995

Alterations in plasma prolyl endopeptidase activity in depression, mania, and schizophrenia: effects of antidepressants, mood stabilizers, and antipsychotic drugs

Michael Maes, Filip Goossens, Simon Scharpé, Joseph R. Calabrese, Roger Desnyder, Herbert Y. Meltzer